The positive data from the Partner 3 trial demonstrates the effectiveness of the Edwards Sapien 3 Valve, which could lead to increased sales and a potential boost in the company's stock price. As the news directly pertains to Edwards Lifesciences, the relevance is high. The importance is also high as this could significantly impact the company's financial performance. The confidence in this analysis is high based on the potential impact of the news on the company's stock price.